注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
COMPASS Pathways PLC是一家總部位於英國的精神保健公司。該公司正在歐洲和北美通過後期臨床試驗為難治性抑鬱症(TRD)患者開發裸蓋菇素療法。本公司已開發出 COMP360,這是一種裸蓋菇素製劑,其中包含其藥用級多晶型結晶裸蓋菇素。該公司的 COMP360已在歐洲和北美的約22個地點完成了裸蓋菇素治療TRD的IIb期臨床試驗。其關於裸蓋菇素治療難治性抑鬱症的隨機對照IIb期研究是裸蓋菇素治療臨床試驗,在10個歐洲和北美國家的約22個地點參與了約233名患者。該試驗評估了三種劑量的COMP360裸蓋菇素治療的安全性和有效性:1mg、10mg、25mg。該公司還在進行COMP360 psilocybin治療創傷後應激障礙(PTSD)的II期臨床試驗。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
David York Norton | 73 | 2018 | Independent Chairman & Lead Independent Director |
Thomas Lonngren | 74 | 2018 | Independent Non-Executive Director |
Annalisa Mary Jenkins | 59 | 2018 | Independent Non-Executive Director |
Kabir Nath | 60 | 2022 | CEO & Director |
Linda R. McGoldrick | 69 | 2020 | Independent Non Executive Director |
Kirk Rutter | - | - | Special Advisor of Patient Experience |
Daphne Karydas | 51 | 2023 | Independent Director |
Alan F. Schatzberg | 79 | - | Member of Scientific Advisory Network |
Paul Summergrad | - | - | Member of Scientific Advisory Network |
Thomas R. Insel | 71 | - | Member of Scientific Advisory Network |
Diego Pizzagalli | - | - | Member of Scientific Advisory Network |
Robert D. McQuade | 67 | 2020 | Independent Non Executive Director |
Gul Dolen | - | - | Member of Scientific Advisory Network |
John Rush | - | - | Member of Scientific Advisory Network |
Wayne Joseph Riley | 65 | 2021 | Independent Non-Executive Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核